Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models
Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Abnormalities in brains of Alzheimer's disease (AD) patients are thought to start long before the first clinical symptoms emerge. The identification of affected individuals at this ‘preclinical AD’ stage relies on biomarkers such as decreased levels of the amyloid‐β peptide (Aβ) in the cerebrospinal fluid (CSF) and positive amyloid positron emissio...
Alternative Titles
Full title
Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c3edd8a53ff64426911680902d63c946
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c3edd8a53ff64426911680902d63c946
Other Identifiers
ISSN
1757-4676
E-ISSN
1757-4684
DOI
10.15252/emmm.201505026
